Please use this identifier to cite or link to this item:
|Title:||Effect of bis (acetato)tetrakis (imidazole) copper(II) in delaying the onset and reducing the mortality rate of strychnine- and thiosemicarbazide- induced convulsions||Authors:||Abdul Ghani, Abdul Salam
Abu Hijleh, Abdullatif
|Keywords:||Copper compounds - Therapeutic use;Copper compounds - Physiological effect;Anticonvulsants - Mechanism of action||Issue Date:||2004||Abstract:||The anticonvulsant activity of bis(acetato)tetrakis(imidazole) copper(II), Cu(OAc)2(Im)4, was studied in normal mice using chemical convulsions induced by strychnine, thiosemicarbazide, picrotoxin, and pentelenetetrazol. Intraperitoneal administration of Cu(OAc) 2(Im)4, 50 mg/kg body mass, has delayed the onset of strychnine (3 mg/kg)-induced convulsion by 204% (p≤0.005) and thiosemicarbazide (20 mg/kg)-induced convulsant by 61% (p≤0.005). The changes in the onset of picrotoxin-(6 mg/kg) and pentelenetetrazol (50 mg/kg)-induced convulsions were not significant. The same dosage of the copper compound was effective in delaying the lethal time and reducing the mortality rate of treated animals. The anticonvulsant activity of Cu(OAc) 2(Im)4 complex against strychnine was not related to its constituents because the inorganic form of copper such as copper chloride, copper acetate, and the parent imidazole has no anticonvulsant activity. Other copper(II) complexes like copper(II)aspirinate and bis(acetato)bis(2-methyl imidazole) copper(II) were less effective.||URI:||http://hdl.handle.net/20.500.11889/3938|
|Appears in Collections:||Fulltext Publications|
Show full item record
checked on Nov 22, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.